Icon
+91 94997 68112
Login Register

Pristiq - (50mg, 100mg; Tablet, extended release)

Desvenlafaxine Succinate Pfizer
50mg, 100mg; Tablet, extended release
Less Than $1000 mn
More Than 5
More Than 5
Less Than 5
 None
More Than 5
More Than 5
Used to treat major depressive disorder.
Yes
******, ******, ******, ******, *********** (*******), ****, *****, ******, *****, *********, ** *****'* *** ***** *************** ******* ********* ******** ****** ***** ***** **** ** *********** ****** *** - ***** *, **** *** '*** - **** *, ******* ************ ********* ** ******* ** ******** . ********** ** ******* **** *** *** **** ** ****** ***** *** ***** ** ********** *** *** *****. ** **** **, ****, *******, *****, ****** *** ***** ******** ********. **** ** *** ******* ********* ******** *** ******* ***** ***** *, ****. *****,***** *** **** ******** *** ******* ** ***** ****.
Pristiq Patent 1 Patent 2
****** ******* *******
****** ******* *******
****** ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** *** **, **** ******* **** ****** **** ********
****** *** \ ** *** **, **** ******* ******** ******** ** ***** **, ****
****** *** \ ** *** **, **** ******* **** ****** **** ********
  1. ***, **** : ******, ******, ******, ******, ***********, ****, *****, ******, *****, ********* *** ***** *********************** ****** ***** *** **** ** *********** ****** "*** ******** ******* ** *** *** **.
  2. **** **, **** : ****** **** ******, ******, ******, ******, ***********, ****, *****, ******, *****, ********* *** ***** *************** ** ******** ***** ** ********.
  3. **** **, **** : ****** **** ****** ** ******* ******** ** **********, ****** ** ******** ******** ** *******, ****** *** ***** ** ******** ***** ** *** ******.
  4. **** **, **** : ****** **** ***** ** ******** ******** ** **** ********.
  5. **** *, **** : ****** **** ****** ** ******** ******** ** ****.
  6. *** **, **** : ********** ********* **** ****** ******
  7. *****, **** : ** *****'* ******** ****** ***** *** **** **** **** ** **** ******* '*** - *** **, **** *** '*** - **** *, ****.
  8. *** *, **** : ********** **** **** *** ********* ***** *** ***** ** ********* *** *** *****.
  9. **** *, **** : ****** **** ** *****'* ** ******** ** ********.
  10. *** *, **** : ****** ***** * **** ******* ******* ****** ** ******** ***** ** ******** ** ******* ****** ***** **** ** **** ******* '*** - *** **, **** *** '*** - **** *, ****.
  11. *** *, **** : ********** **** ********* *** ********* ***** *** ***** ** ********* *** *** *****.
  12. *** *, **** : ********** **** ***** *** ********* ***** *** ***** ** ********* *** *** *****.
  13. *** **, **** : ********** **** ****** *** ********* ***** *** ***** ** ********* *** *** *****.
  14. *** *, **** : ********** **** ******, *****, ****** *** ********* ***** *** ***** ** ********* *** *** *****.
  15. *** **, **** : ********** **** ****** ** ********* ***** *** ***** ** ********* ** *** *****.
  16. *** **, **** : ********** **** ******* *** ************ *** ********* ***** *** ***** ** ********* *** *** *****.
  17. *** **, **** : ********** **** ***** *** ** *****'* *** ********* ***** ***** ** ********* *** *** *****.
  18. *** *, **** : ********** **** ******* ***** *** ********* ***** *** ***** ** ********* *** *** *****.
  19. *** **, **** : *******, ******, ***** *** ***** ******** ********.
  20. *** *, **** : ***** *** **** ******** *** *******.

Pristiq - (25mg, tablet, extended release)

Desvenlafaxine Succinate Pfizer
25mg, tablet, extended release
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
More Than 5
More Than 5
Used to treat major depressive disorder
Yes
*** ********* ***.
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
** *******
  1. *** **, **** : * **** ** ** ***** *** ******* ** ******* *** *******
  2. *** **, **** : ******* *** ********
  3. *** **, **** : ******* *** ***** ********
  4. *** **, **** : ******* *** ********. *****://***.**********.***.***/**********_****/*********/****/******************.***
  5. *** **, **** : ***** *** ***** ********
  6. *** **, **** : ******* *** ***** ******** *** ******** *** *******

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.